These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11445189)

  • 1. Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes.
    Herdon HJ; Godfrey FM; Brown AM; Coulton S; Evans JR; Cairns WJ
    Neuropharmacology; 2001 Jul; 41(1):88-96. PubMed ID: 11445189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.
    Harsing LG; Gacsalyi I; Szabo G; Schmidt E; Sziray N; Sebban C; Tesolin-Decros B; Matyus P; Egyed A; Spedding M; Levay G
    Pharmacol Biochem Behav; 2003 Mar; 74(4):811-25. PubMed ID: 12667895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action.
    Javitt DC; Duncan L; Balla A; Sershen H
    Mol Psychiatry; 2005 Mar; 10(3):275-87. PubMed ID: 15278098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport.
    Aubrey KR; Vandenberg RJ
    Br J Pharmacol; 2001 Dec; 134(7):1429-36. PubMed ID: 11724748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior.
    Kinney GG; Sur C; Burno M; Mallorga PJ; Williams JB; Figueroa DJ; Wittmann M; Lemaire W; Conn PJ
    J Neurosci; 2003 Aug; 23(20):7586-91. PubMed ID: 12930797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms.
    Harsing LG; Timar J; Szabo G; Udvari S; Nagy KM; Marko B; Zsilla G; Czompa A; Tapolcsanyi P; Kocsis A; Matyus P
    Curr Pharm Des; 2015; 21(17):2291-303. PubMed ID: 25578890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GlyT1 Inhibitor NFPS Exerts Neuroprotection via GlyR Alpha1 Subunit in the Rat Model of Transient Focal Cerebral Ischaemia and Reperfusion.
    Huang B; Xie Q; Lu X; Qian T; Li S; Zhu R; Yu W; Chen G; Chen Z; Xu X; Wang T; Li L
    Cell Physiol Biochem; 2016; 38(5):1952-62. PubMed ID: 27161043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
    Kim KM; Kingsmore SF; Han H; Yang-Feng TL; Godinot N; Seldin MF; Caron MG; Giros B
    Mol Pharmacol; 1994 Apr; 45(4):608-17. PubMed ID: 8183239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model.
    Mohammadzadeh A; Lakatos PP; Balogh M; Zádor F; Karádi DÁ; Zádori ZS; Király K; Galambos AR; Barsi S; Riba P; Benyhe S; Köles L; Tábi T; Szökő É; Harsing LG; Al-Khrasani M
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some Operational Characteristics of Glycine Release in Rat Retina: The Role of Reverse Mode Operation of Glycine Transporter Type-1 (GlyT-1) in Ischemic Conditions.
    Hanuska A; Szénási G; Albert M; Koles L; Varga A; Szabo A; Matyus P; Harsing LG
    Neurochem Res; 2016 Feb; 41(1-2):73-85. PubMed ID: 26364050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
    Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices.
    Huang H; Barakat L; Wang D; Bordey A
    J Physiol; 2004 Nov; 560(Pt 3):721-36. PubMed ID: 15331688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of striatal dopamine release by glycine transport inhibitors.
    Javitt DC; Hashim A; Sershen H
    Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motorneurons.
    Lim R; Hoang P; Berger AJ
    J Neurophysiol; 2004 Oct; 92(4):2530-7. PubMed ID: 15175365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter.
    Atkinson BN; Bell SC; De Vivo M; Kowalski LR; Lechner SM; Ognyanov VI; Tham CS; Tsai C; Jia J; Ashton D; Klitenick MA
    Mol Pharmacol; 2001 Dec; 60(6):1414-20. PubMed ID: 11723250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
    Hashimoto K; Fujita Y; Ishima T; Chaki S; Iyo M
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):414-21. PubMed ID: 17804206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo.
    Chen L; Muhlhauser M; Yang CR
    J Neurophysiol; 2003 Feb; 89(2):691-703. PubMed ID: 12574447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules - glycine transporter type 1 and its inhibitors (review).
    Harsing LG; Zsilla G; Matyus P; Nagy KM; Marko B; Gyarmati Z; Timar J
    Acta Physiol Hung; 2012 Mar; 99(1):1-17. PubMed ID: 22425803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.